Hydroxyprogesterone Caproate
- Product NDC
- 0517-1791
- 11-digit product format
- 005171791
- Labeler code
- 0517
- Product ID
- 0517-1791_abe2312b-bc06-497b-835e-b9526fbe09bf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydroxyprogesterone Caproate
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR
- Labeler
- American Regent, Inc.
- Application
- ANDA210723
- Marketing category
- ANDA
- Marketing start
- 2019-03-01
- Marketing end
- 0000-00-00
- Substance
- HYDROXYPROGESTERONE CAPROATE
- Active strength
- 250 mg/mL
- Pharmacologic classes
- Progesterone Congeners [CS],Progestin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0517-1791-01 | 00517179101 | 1 VIAL in 1 BOX (0517-1791-01) > 1 mL in 1 VIAL | 1 vial | 2019-03-01 | 0000-00-00 | No | No | Current |